
INVESTIGATION OF TLR4 POLYMORPHISM IN CHILDREN WITH VESICOURETERAL REFLUX AND RENAL SCARRING Sav NM1*, Eroz R2, Kalay Duran N3, Kilicaslan O4, Erisen Karaca S5 *Corresponding Author: *Corresponding Author: Nadide Melike SAV, Address: Duzce Universitesi Araştırma Uygulama Hastanesi, Pediatrik Nefroloji B.D, Merkez, DUZCE, TURKEY; Phone: +905378683281; Fax:+903805421390; e-mail address: savmelike@gmail.com page: 41
|
MATERIALS AND METHOD
This cross-sectional study was carried out with 49
patients who were followed up due to primary vesico-
ureteral reflux at Duzce University, Faculty of Medicine,
Department of Pediatric Nephrology, Duzce, Turkey.
Patients under 18 years of age with VUR and recur-
rent UTIs were included in the study. Oral and written
informed consent was obtained from all individual partici-
pants and their families included in the study. Those who
did not give consent and those who had additional renal
or other system anomalies and patients with stage 5 CKD
were excluded. The study protocol was approved by the
Institutional Ethics Committee of Duzce University School
of Medicine (Ethics No: 2019/285). The study was con-
ducted by the ethical principles set forth in the Declaration
of Helsinki. This project was supported by the Scientific
Research Project Department of Duzce University (Grant
number: 2021.04.03.1194).
Diagnosis of UTI was made based on history and
exam findings and confirmed with appropriately collect-
ed urine. The presence of VUR was confirmed by voiding
cystourethrography (VCUG) and the severity of VUR
was graded according to the International Reflux Study in
Children (IRSC) (I-V) [7]. A DMSA scan was performed
6 months after the last UTI. Patients were divided into
two groups according to the presence of any kidney scars
determined in the DMSA scan. Office blood pressure
was measured by the auscultation method. Before start-
ing blood pressure measurements, the patient rested in a
sitting position for at least 3-5 minutes, relaxed and rested.
The arm was outstretched, in line with the mid-sternum
and supported. An appropriately sized cuff was wrapped
around the upper arm and connected to a manometer and
blood pressure was measured.
Genomic DNA was isolated from 200 μl peripheral
leukocytes of the cases using DNA isolation kits (Anatolia
Diagnostics and Biotechnology Products Inc., Istanbul,
Turkey). Polymerase chain reaction (PCR) pools generated
before the NGS reaction were purified by the NucleoFast
96 PCR (MACHEREY-NAGEL GmbH) kit. Then the
quantification of the PCR products was standardized on
NanoDrop 1000 (Thermo Fisher Scientific Inc.) and the
TLR4 gene was sequenced by NGS (MISEQ-Illumina). Se-
rum and urine biochemical parameters were also recorded.
Statistical Analysis
The data were analyzed via IBM SPSS Statistics
22.0 (IBM Corp. Released 2013. IBM SPSS Statistics for
Windows, Version 22.0. Armonk, NY: IBM Corp.). The
Shapiro-Wilk test was performed to examine the distribu-
tion of data. All quantitative variables were reported by
mean±standard deviation (SD) and median (interquartile
range: IQR), as categorical variables were summarized
by frequency and %. The Mann-Whitney U test was per-
formed to compare the patients with and without scares
with respect to the quantitative variables. Pearson chi-
square test, Fisher’s exact test and Fisher-Freeman-Halton
test were used to reveal the differences between two groups
for categorical variables. A p-value≤0.05 was considered
statistically significant.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|